What we do

We provide chemistry services and are capable of supplying products from gram to multi kilo scale involving complex and multi-step synthesis. We supply to biotech and pharma customers to support their early stage drug discovery and pre-clinical to clinical research activities. We have partnered with WHO GMP and ISO 9001-2008 facilities located in India manufacturing APIs and intermediates. We conduct process R&D, technology transfer and manufacture of key starting materials, advanced intermediates for APIs going to clinical studies.

We also conduct process development and manufacture of advanced intermediates for Generic APIs in partnership with Indian facilities. In addition we develop and synthesize stable deuterium labelled drug standards and metabolites and supply to leading pharmaceutical companies all over the world. We also develop and manufacture semiochemicals for crop protection, specialty chemicals for photography applications.

Custom Synthesis

We perform synthesis of intermediate, reference or lead compounds
We can also exercise an existing synthesis or design a new synthesis when there is no developed chemical plan

Process Research

Can undertake projects for process research, scale up and technology commercialization for preclinical and clinical drug candidates, APIs, pharmaceutical intermediates and specialty chemicals in our cGMP compliant facilities

Drug-like and Lead-like Compounds for Screening

We provide a diverse library of small molecule compounds for screening against your targets
We can create a synthesis plan for your hit compounds
We can design and synthesize a custom library for lead identification and lead optimization

Why SVChemBiotech?

Our experience, combined with state-of- the-art laboratories and manufacturing facilities lets us become an ideal partner for the pharmaceutical and drug discovery industry. We work efficiently and offer a competitive price while maintaining full confidentiality regarding clients` intellectual property.

Inhibitors Compound - Brochure